Department of Pediatrics, Faculty of Medicine, Sohag University, 15 University Street, Sohag, 82524, Egypt.
Department of Clinical Pathology, Faculty of Medicine, Sohag University, Sohag, Egypt.
Ital J Pediatr. 2021 Jan 12;47(1):7. doi: 10.1186/s13052-021-00965-1.
Neonatal thrombocytopenia (NT) (platelet count < 150 × 10/L) is a common finding in the neonatal intensive care unit (NICU). The main aim of this study was to assess the prevalence, risk factors, and outcomes of severe NT in full term (FT) infants.
During the study period, all FT infants who met the inclusion criteria for NT on two occasions were included. Maternal data, such as maternal age, weight, gestational age, mode of delivery, and history of systemic diseases, including diabetes mellitus, pre-eclampsia, systemic lupus erythematosus, and immune thrombocytopenic purpura, were recorded. Furthermore, neonatal data, such as gender, neonatal weight, causes/duration of admission, types of respiratory support used, complete blood count measurements, and outcomes for neonates admitted to the NICU, were recorded.
In total, 55 FT infants with NT met the inclusion criteria, and 29 (52.73%) cases had severe NT. The most common cause of NT was neonatal sepsis (20 cases, 36.35%), followed by a postoperative state (5 cases, 9.09%). Moreover, in cases of positive blood cultures, the most commonly isolated organism was Escherichia coli (6 cases, 10.90%), followed by Klebsiella (5 cases, 9.09%). Cases of severe NT needed more platelet transfusions (P = 0.001) and had higher rates of mortality (P = 0.001) when compared to cases of mild/moderate NT associated with signs of bleeding and pulmonary/intraventricular hemorrhage (IVH) (P = 0.001).
Severe NT compared to mild/moderate NT, associated with signs of bleeding and pulmonary/IVH, needed more platelet transfusions, and had increased mortality. Further research is needed to explain which of these complications related to severity of thrombocytopenia or were associated with original disease of the babies.
新生儿血小板减少症(NT)(血小板计数<150×10/L)在新生儿重症监护病房(NICU)中很常见。本研究的主要目的是评估足月(FT)婴儿重度 NT 的患病率、危险因素和结局。
在研究期间,所有符合两次 NT 纳入标准的 FT 婴儿均被纳入。记录了母体数据,如母亲年龄、体重、胎龄、分娩方式以及包括糖尿病、子痫前期、系统性红斑狼疮和免疫性血小板减少性紫癜在内的全身疾病史。此外,还记录了新生儿数据,如性别、新生儿体重、入院原因/时间、使用的呼吸支持类型、全血细胞计数测量值以及入住 NICU 的新生儿结局。
共有 55 名 FT 婴儿符合 NT 纳入标准,其中 29 名(52.73%)为重度 NT。NT 的最常见原因是新生儿败血症(20 例,36.35%),其次是术后状态(5 例,9.09%)。此外,在血培养阳性的病例中,最常见的分离菌是大肠杆菌(6 例,10.90%),其次是克雷伯菌(5 例,9.09%)。与有出血和肺/脑室内出血(IVH)迹象的轻度/中度 NT 相比,重度 NT 病例需要更多的血小板输注(P=0.001),死亡率更高(P=0.001)。
与有出血和肺/IVH 迹象的轻度/中度 NT 相比,重度 NT 需要更多的血小板输注,且死亡率更高。需要进一步研究来解释这些并发症是与血小板减少症的严重程度相关,还是与婴儿的原始疾病相关。